标题
Azaaurones as Potent Antimycobacterial Agents Active against MDR‐ and XDR‐TB
作者
关键词
-
出版物
ChemMedChem
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-07-11
DOI
10.1002/cmdc.201900289
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Mycobacterial genomics and structural bioinformatics: opportunities and challenges in drug discovery
- (2019) Vaishali P. Waman et al. Emerging Microbes & Infections
- Aurone: A biologically attractive scaffold as anticancer agent
- (2019) Abdulrahman Alsayari et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Aurone derivatives as promising antibacterial agents against resistant Gram-positive pathogens
- (2019) Hamza Olleik et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Crystal Structures of Membrane Transporter MmpL3, an Anti-TB Drug Target
- (2019) Bing Zhang et al. CELL
- Drug discovery in tuberculosis. New drug targets and antimycobacterial agents
- (2018) André Campaniço et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis
- (2018) Sunil Kumar et al. TUBERCULOSIS
- The present state of the tuberculosis drug development pipeline
- (2018) M Daben J Libardo et al. CURRENT OPINION IN PHARMACOLOGY
- Bedaquiline and delamanid in the treatment of multidrug‐resistant tuberculosis: Promising but challenging
- (2018) Yang Li et al. DRUG DEVELOPMENT RESEARCH
- Bedaquiline and linezolid MIC distributions and epidemiological cut-off values for Mycobacterium tuberculosis in the Latin American region
- (2018) Beatriz Lopez et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Identification and Profiling of Hydantoins—A Novel Class of Potent Antimycobacterial DprE1 Inhibitors
- (2018) Maciej K. Rogacki et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery and Structure–Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-d-ribose 2′-Oxidase
- (2018) Sangmi Oh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence
- (2017) Emanuele Pontali et al. EUROPEAN RESPIRATORY JOURNAL
- Targeting Energy Metabolism in Mycobacterium tuberculosis , a New Paradigm in Antimycobacterial Drug Discovery
- (2017) Dirk Bald et al. mBio
- The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
- (2017) Keertan Dheda et al. Lancet Respiratory Medicine
- A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors
- (2017) Marta Esposito et al. ACS Infectious Diseases
- Probing the Azaaurone Scaffold against the Hepatic and Erythrocytic Stages of Malaria Parasites
- (2016) Marta P. Carrasco et al. ChemMedChem
- Current challenges in drug discovery for tuberculosis
- (2016) Anuradha Kumar et al. Expert Opinion on Drug Discovery
- Beyond extensively drug-resistant tuberculosis in Lisbon, Portugal: a case of linezolid resistance acquisition presenting as an iliopsoas abscess
- (2016) João Perdigão et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Delamanid in the treatment of multidrug-resistant tuberculosis
- (2016) R. Gupta et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- 2-Hydroxypyridine-N-oxide-Embedded Aurones as Potent Human Tyrosinase Inhibitors
- (2016) Romain Haudecoeur et al. ACS Medicinal Chemistry Letters
- Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening
- (2015) Ujjini H. Manjunatha et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Pyrrolo[3,4-c]pyridine-1,3(2H)-diones: A Novel Antimycobacterial Class Targeting Mycobacterial Respiration
- (2015) Renier van der Westhuyzen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal
- (2015) Keira A. Cohen et al. PLOS MEDICINE
- Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment?
- (2015) Stephen K. Field Therapeutic Advances in Chronic Disease
- Novel Insights into the Mechanism of Inhibition of MmpL3, a Target of Multiple Pharmacophores in Mycobacterium tuberculosis
- (2014) Wei Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Respiratory Flexibility in Response to Inhibition of CytochromecOxidase in Mycobacterium tuberculosis
- (2014) Kriti Arora et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Unraveling Mycobacterium tuberculosis genomic diversity and evolution in Lisbon, Portugal, a highly drug resistant setting
- (2014) João Perdigão et al. BMC GENOMICS
- Probing the aurone scaffold against Plasmodium falciparum: Design, synthesis and antimalarial activity
- (2014) Marta P. Carrasco et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- B-ring modified aurones as promising allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase
- (2014) Amel Meguellati et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects
- (2014) Alimuddin I Zumla et al. LANCET INFECTIOUS DISEASES
- Bedaquiline for the treatment of resistant tuberculosis: Promises and pitfalls
- (2014) Ashish Kumar Kakkar et al. TUBERCULOSIS
- A medicinal chemists’ guide to the unique difficulties of lead optimization for tuberculosis
- (2013) Véronique Dartois et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis
- (2013) Lluís Ballell et al. ChemMedChem
- Development of Mycobacterium tuberculosis Whole Cell Screening Hits as Potential Antituberculosis Agents
- (2013) Christopher B. Cooper JOURNAL OF MEDICINAL CHEMISTRY
- Exploring the Contribution of Mycobacteria Characteristics in Their Interaction with Human Macrophages
- (2013) Carla Silva et al. MICROSCOPY AND MICROANALYSIS
- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
- (2013) Kevin Pethe et al. NATURE MEDICINE
- A Dual Read-Out Assay to Evaluate the Potency of Compounds Active against Mycobacterium tuberculosis
- (2013) Juliane Ollinger et al. PLoS One
- Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?
- (2013) Robert C. Goldman TUBERCULOSIS
- Pathway-Selective Sensitization of Mycobacterium tuberculosis for Target-Based Whole-Cell Screening
- (2012) Garth L. Abrahams et al. CHEMISTRY & BIOLOGY
- Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis
- (2012) Scott G. Franzblau et al. TUBERCULOSIS
- The developability of heteroaromatic and heteroaliphatic rings – do some have a better pedigree as potential drug molecules than others?
- (2012) Timothy J. Ritchie et al. MedChemComm
- The challenge of new drug discovery for tuberculosis
- (2011) Anil Koul et al. NATURE
- High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv
- (2011) Robert C. Reynolds et al. TUBERCULOSIS
- 1-Azaaurones derived from the naturally occurring aurones as potential antimalarial drugs
- (2010) Florence Souard et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and biological evaluation of a novel series of 2,2-bisaminomethylated aurone analogues as anti-inflammatory and antimicrobial agents
- (2010) Babasaheb P. Bandgar et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development
- (2008) J. van den Boogaard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now